Ganfort 0,3 mg/ml Eye drops, solution

Ganfort 0,3 mg/ml Eye drops, solution

S4
PDF Leaflet Revision Date: 21 April 2023

API: Bimatoprost Timolol | Company: AbbVie

Clinical Summary

Quick overview from the medicine insert

Indication

Reduction of intraocular pressure in open-angle glaucoma or ocular hypertension.

Dosage (summary)

One drop in the affected eye(s) once daily.

Special Populations

  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Monitor neonates for signs of beta-blockade; not recommended during breastfeeding.

Key Drug Interactions

  • Systemic beta-blockers
  • Calcium channel blockers
  • Anti-dysrhythmics
  • Digoxin

Contraindications

  • Hypersensitivity to components
  • Reactive airway disease
  • Bradycardia
  • Cardiac failure

Common side effects

  • Conjunctival hyperaemia
  • Headache
  • Rhinitis

Counselling Points

  • Avoid contact with soft contact lenses
  • Monitor for eye irritation
  • Inform about potential eyelash growth

Serious warnings

  • Potential for systemic absorption
  • Caution in cardiovascular disease
  • Risk of bronchospasm
Important Disclaimer

The Ganfort 0,3 mg/ml Eye drops, solution professional information leaflet below is the property of AbbVie and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites